Tina Ružić

Mrs. Tina Ružić

Center for Proteomics, Faculty of Medicine, University of Rijeka
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
TNTsukasa Nabekura
Tsukasa Nabekura
DGDagmar Gotthardt
Dagmar Gotthardt
KNKouta Niizuma
Kouta Niizuma
TTTihana Trsan
Tihana Trsan
TRTina Ružić
Tina Ružić
LLLewis L Lanier
Lewis L Lanier
NK cells play a critical role in host defense against viruses. In this study, we investigated the role of NKG2D in the expansion of NK cells after mouse CMV (MCMV) infection. Wild-type and NKG2D-deficient (Klrk1−/−) Ly49H+ NK cells proliferated robustly when infected with MCMV strains engineered to allow expression of NKG2D ligands, which enhanced the response of wild-type NK cells. Naive NK cells exclusively express NKG2D-L, which pairs only with DAP10, whereas NKG2D-S expressed by activated NK cells pairs with DAP10 and DAP12, similar to Ly49H. However, NKG2D alone was unable to drive robust expansion of Ly49H− NK cells when mice were infected with these MCMV strains, likely because NKG2D-S was only transiently expressed postinfection. These findings demonstrate that NKG2D augments Ly49H-dependent proliferation of NK cells; however, NKG2D signaling alone is inadequate for expansion of NK cells, likely due to only transient expression of the NKG2D–DAP12 complex.

7 May 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LHLea Hiršl
Lea Hiršl
IBIlija Brizić
Ilija Brizić
TRTina Ružić
Tina Ružić
Vanda Juranic LisnicVanda Juranic Lisnic
Vanda Juranic Lisnic
JRJohanna Julia Reichel
Johanna Julia Reichel
SJStipan Jonjić
Stipan Jonjić
The development of a vaccine against human cytomegalovirus (CMV) has been a subject of long-term medical interest. The research during recent years identified CMV as an attractive vaccine vector against infectious diseases and tumors. The immune response to CMV persists over a lifetime and its unique feature is the inflationary T cell response to certain viral epitopes. CMV encodes numerous genes involved in immunoevasion, which are non-essential for virus growth in vitro. The deletion of those genes results in virus attenuation in vivo, which enables us to dramatically manipulate its virulence and the immune response. We have previously shown that the murine CMV (MCMV) expressing RAE-1γ, one of the cellular ligands for the NKG2D receptor, is highly attenuated in vivo but retains the ability to induce a strong CD8+ T cell response. Here, we demonstrate that recombinant MCMV expressing high affinity NKG2D ligand murine UL16 binding protein-like transcript (MULT-1) (MULT-1MCMV) inserted in the place of its viral inhibitor is dramatically attenuated in vivo in a NK cell-dependent manner, both in immunocompetent adult mice and in immunologically immature newborns. MULT-1MCMV was more attenuated than the recombinant virus expressing RAE-1γ. Despite the drastic sensitivity to innate immune control, MULT-1MCMV induced an efficient CD8+ T cell response to viral and vectored antigens. By using in vitro assay, we showed that similar to RAE-1γMCMV, MULT-1 expressing virus provided strong priming of CD8+ T cells. Moreover, MULT-1MCMV was able to induce anti-viral antibodies, which after passing the transplacental barrier protect offspring of immunized mothers from challenge infection. Altogether, this study further supports the concept that CMV expressing NKG2D ligand possesses excellent characteristics to serve as a vaccine or vaccine vector.

22 August 2018 in European Addiction Research
Verified
Journal Article
Closed access
PDF file
DRDarko Roviš
Darko Roviš
MBMaša Černelič Bizjak
Maša Černelič Bizjak
VVVanja Vasiljev
Vanja Vasiljev
APAna Petelin
Ana Petelin
TRTina Ružić
Tina Ružić
ZPZala Jenko Pražnikar
Zala Jenko Pražnikar
Background: This study has examined the relationships and interactions between serum brain-derived neurotrophic factor (BDNF) levels, BDNF Val66Met polymorphism and self-reported risk-taking behaviour in individuals with a history of heroin use undergoing outpatient treatment in comparison to healthy individuals. Methods: We enrolled 167 heroin users and 86 healthy subjects and examined serum BDNF levels, Val66Met polymorphism, and personal characteristics using Connor Davidson Resilience Scale, Risk-taking (RT) propensity questionnaire, and Personality Assessment Inventory. Results: Heroin users had significantly higher serum BDNF levels than controls. In addition, serum BDNF levels were significantly higher in Val/Val carriers than in Met/Val or Met/Met in all recruited subjects. Furthermore, a stepwise multiple regression analysis of serum BDNF levels as a dependent variable with related factors showed that in heroin users, Alcohol Use Disorder Identification Test score, anxiety and RT score were found as independent contributors to serum BDNF levels. When performing gene-environment interaction it was additionally found that heroin users with self-reported high risk-taking behaviour had significantly lower levels of serum BDNF among heroin users with the Met allele. Conclusions: These results indicate that genetic variant Met66 decreased the serum BDNF levels in combination with self-reported risk-taking propensity among heroin users. If results of future work confirm the influence of this combined effect between neurotrophic genotype and risk-taking behaviour, 66Met carriers might require higher levels of intervention to overcome their drug use pattern and risky behaviour.

2 December 2021 in Viruses
Verified
Journal Article
Open access
PDF file
MPMartina Pavletić
Martina Pavletić
Marija MazorMarija Mazor
Marija Mazor
MLMate Lerga
Mate Lerga
TMTatjana Mileta
Tatjana Mileta
JŽJelena Železnjak
Jelena Železnjak
Vanda Juranic LisnicVanda Juranic Lisnic
Vanda Juranic Lisnic
During COVID-19 pandemics, the availability of testing has often been a limiting factor during patient admissions into the hospital. To circumvent this problem, we adapted an existing diagnostic assay, Seegene Allplex SARS-CoV-2, into a point-of-care-style direct qPCR (POC dqPCR) assay and implemented it in the Emergency Department of Clinical Hospital Center Rijeka, Croatia. In a 4-month analysis, we tested over 10,000 patients and demonstrated that POC-dqPCR is robust and reliable and can be successfully implemented in emergency departments and similar near-patient settings and can be performed by medical personnel with little prior experience in qPCR.

26 January 2022 in Journal of Virology
Verified
Journal Article
Closed access
TRTina Ružić
Tina Ružić
Vanda Juranic LisnicVanda Juranic Lisnic
Vanda Juranic Lisnic
Hana Mahmutefendić LučinHana Mahmutefendić Lučin
Hana Mahmutefendić Lučin
TRTihana Lenac Rovis
Tihana Lenac Rovis
JŽJelena Železnjak
Jelena Železnjak
BLBerislav Lisnić
Berislav Lisnić
Human cytomegalovirus (HCMV) is a species-specific herpesvirus that causes severe disease in immunocompromised individuals and immunologically immature neonates. Murine cytomegalovirus (MCMV) is biologically similar to HCMV, and it serves as a widely used model for studying the infection, pathogenesis, and immune responses to HCMV.